Search results
Four-plex test for SARS-CoV-2, Influenza A/B and RSV receives FDA Emergency Use Authorization. Now, HCPs will be able to detect and differentiate these respiratory viruses within a single patient visit, enabling improved public health outcomes.
Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases.
Roche Diagnostics develops and produces medical tests and digital tools that provide information to help healthcare professionals find the right treatment for patients and deliver the best patient care to improve, prolong and save lives.
We combine science, data and insights to transform the way diseases can be prevented, diagnosed and monitored. Our medical assays, digital solutions and services help people live healthier lives.
More than 800,000 documents available on demand for Centralized Diagnostics, Tissue Diagnostics, Molecular Diagnostics, Life Science, Sequencing and Custom Biotech product information.
From screening and diagnosis to follow-up monitoring, people, laboratories, and point-of-care settings benefit from Roche’s comprehensive portfolio of infectious disease diagnostic solutions. Learn how innovation is helping healthcare systems meet demand.
For healthcare providers, we offer virtual care and decision support solutions to confidently diagnose, optimise resources and help personalise treatment. For patients, we offer digital diagnostic solutions for self-monitoring and the delivery of test results.
